Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.

Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.

Item
http://www.wikidata.org/entity/Q33369393
Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer.Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancerAssociation between the low-dose irinotecan regimen-induced occurrence of grade 4 neutropenia and genetic variants of UGT1A1 in patients with gynecological cancers.First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study.FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic OFirst-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancerPalliative chemotherapy for patients 70 years of age and older with metastatic colorectal cancer: a single-centre experienceTolerance to chemotherapy in elderly patients with cancer.Colorectal cancer treatment in older patients.Role of chemotherapy and novel biological agents in the treatment of elderly patients with colorectal cancer.Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression.Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy.Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.Challenges in the management of older patients with colon cancerRandomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02).Phase II study of a combination of irinotecan and S-1 in patients with advanced gastric cancer (OGSG0002).
P2860

Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.

Item
http://www.wikidata.org/entity/Q33369393
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Combination of irinotecan (CPT ...... ctal cancer: a phase II trial.
@ast
Combination of irinotecan (CPT ...... ctal cancer: a phase II trial.
@en
type
label
Combination of irinotecan (CPT ...... ctal cancer: a phase II trial.
@ast
Combination of irinotecan (CPT ...... ctal cancer: a phase II trial.
@en
prefLabel
Combination of irinotecan (CPT ...... ctal cancer: a phase II trial.
@ast
Combination of irinotecan (CPT ...... ctal cancer: a phase II trial.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Combination of irinotecan (CPT ...... ctal cancer: a phase II trial.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921